Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial.
Chun-Juan WangHong-Qiu GuQiang DongLiangxue LaiNing WangYi YangFeng WangYong-Jun WangPublished in: Stroke and vascular neurology (2024)
The TASTE-2 trial will provide evidence to determine whether the administration of edaravone dexborneol in AIS patients undergoing EVT could yield significant improvements in neurological function.